CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...

When Mizuho healthcare equity strategist Jared Holz spoke to Barron’s for our annual healthcare roundtable last month, the ...

Leverage RWE strategically to build regulator-ready submissions.

Microsoft has backed out of building data centers, Intel's factory opening has been delayed to 2030, but one tech industry is going strong in central Ohio: Biotechnology. The now multibillion dollar ...

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus.

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy. A full transcript is below. This ...

XBI is a biotech-focused ETF offering equal-weight exposure to U.S. biotechnology companies. The SPDR S&P Biotech ETF tracks the performance of the S&P Biotechnology Select Industry Index. XBI ...